Herriot Tabuteau, Chief Executive Officer, 10% Owner at Axsome Therapeutics, Inc. (AXSM), sold 49,666 shares at $240.25 ($11.9M) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Scheduled sale ($11.9M) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AXSM | SELL | 2026-02-02 | $6.0M | — | Filing → |
| AXSM | SELL | 2026-01-07 | $23.9M | — | Filing → |
| AXSM | SELL | 2025-12-04 | $23.3M | — | Filing → |